Values Interventions for Increasing Engagement With What is Feared in

Status Completed

Clinical Trial Summary

Exposure is considered the therapy of choice for specific phobias (SPs). Nevertheless, therapy engagement is extremely limited. SPs are maintained through avoidance of feared stimuli and as such willingness to approach what is feared constitutes a key factor that could explain limited treatment engagement. Values interventions, a key element of acceptance and commitment therapy (ACT), might be one way to increase engagement, yet to this date limited research exists in this area. For the purposes of the current study, two brief values interventions were developed: (a) a personal and (b) a prosocial one. These will be compared to (c) a no-instructions control in increasing willingness to approach and approach behaviour towards phobic stimuli. Ninety participants with flying phobia will be randomly allocated to one of the three groups. To measure willingness to engage with feared stimuli and approach behaviour two behavioural approach tasks using novel technologies (virtual reality), which aimed to expose participants to situations analogous to real life, were developed. Willingness and behavioural approach towards airplanes at a one month follow up will also be assessed. Therefore, it is hypothesised that: 1. Participants in either of the two values intervention groups will have greater willingness to engage and approach behaviour towards feared stimuli compared to those in control, during the study tasks. 2. Participants in either of the two values intervention groups will have greater willingness to engage and approach behaviour towards feared stimuli compared to those in control at follow up. Additionally, as prosocial values provide an evolutionary advantage, the second study aim was to identify if they lead to greater engagement with phobic stimuli compared to personal ones. Therefore, it was also hypothesised that: 3. Participants in the prosocial values group will have greater willingness to engage and approach behaviour towards feared stimuli compared to those in personal values group, both during the study tasks and at follow up. 4. Participants in the prosocial values group will have greater willingness to engage and approach behaviour towards feared stimuli compared to those in personal values group at follow up.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05300061
Study type	Interventional
Source	University of Cyprus
Contact
Status	Completed
Phase	N/A
Start date	September 1, 2020
Completion date	May 14, 2021

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04594525` - Maternal Telemental Health Interventions in Response to Covid-19*	N/A
Completed	`NCT02306356` - Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical Setting	N/A
Completed	`NCT03233113` - The Effects of Safety Seeking Behaviors During Exposure Therapy for Adults With Spider Phobia	N/A
Completed	`NCT04504773` - Using Immersive Virtual Reality to Treat Pediatric Anxiety	N/A
Completed	`NCT03208400` - Virtual Reality Exposure in Spider Phobia	N/A
Completed	`NCT03688360` - Facing Fears In-session or Out-session?	N/A
Completed	`NCT03688373` - Facing Fears in Big or Smalls Steps?	N/A
Recruiting	`NCT02305537` - Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment	N/A
Terminated	`NCT01979263` - Attention Bias Modification Treatment for Anxious Youth	N/A
Terminated	`NCT03764644` - Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders	N/A
Not yet recruiting	`NCT02972112` - Ultrashort Cognitive Behavioral Intervention for Tokophobia- A Prospective Randomized Single Blinded Controlled Trial	N/A
Completed	`NCT02554838` - How to Act on the Mobility Restriction Linked to Senior's Phobia of Falling	N/A
Completed	`NCT01491880` - Treatment Study for Rural Latino Youth With Anxiety	Phase 1/Phase 2
Completed	`NCT01947647` - Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders	N/A
Recruiting	`NCT04563390` - Effectiveness of a Projection-based Augmented Reality Exposure System in Treating Cockroach Phobia.	N/A
Completed	`NCT05284435` - Internet-Based, Parent-Led Cognitive-Behavioral Therapy for Anxiety in Youth With ASD	N/A
Completed	`NCT03105024` - Self-efficacy Enhancement and Exposure Therapy	N/A
Completed	`NCT01923896` - D-cycloserine and Treatment of Feeding Disorders	Phase 1/Phase 2
Recruiting	`NCT03917550` - RECOVERY: A Transdiagnostic Intervention for Anxiety and Depression	N/A
Completed	`NCT02756507` - Transdiagnostic REBT Prevention Program for Adolescents	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Values Interventions for Increasing Engagement With What is Feared in Individuals With Specific Phobias

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms